Purchase Order HT941024P0135
Award Date
4/17/24
Potential Completion Date
4/16/29
Potential Value
$1M
Federal Agency
Defense Health Agency
Awardee
Ortho-Clinical Diagnostics, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6630 - Chemical Analysis Instruments
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
WHIDBEY ISLAND NAVAL AIR, WA 98278, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,180,281.57 firm fixed-price purchase order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture based in Rochester, New York. The contract is for the provision of clinical chemistry reagents, with a performance period from October 1, 2021 through September 30, 2026. The contract was awarded without a set-aside designation and is not associated with a larger contract...
This is a firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (part of the Department of the Navy) to Ortho-Clinical Diagnostics, Inc. for supplies and services related to the PROVUE analyzer. The contract has a ceiling value of $101,729.62 and a period of performance ending on September 30, 2015. Ortho-Clinical Diagnostics is a for-profit medical equipment manufacturer and supplier, classified as a self-certified HUBZone joint venture. The contract does not...
This is a $201,077.28 firm fixed price purchase order awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc. to provide chemistry analyzer maintenance and services. The contract has an ultimate completion date of September 30, 2027. Ortho-Clinical Diagnostics is a medical equipment manufacturing company that supports various federal agencies with diagnostic solutions and laboratory services. This contract does not have a set-aside designation. The award is part of...
This is a delivery order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer and HUBZone joint venture, for cost-per-test reagents, equipment, and services under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule. The contract has a ceiling value of $193,372.98 and a period of performance ending on September 30, 2026. It is a firm-fixed price contract with no set-aside designation, indicating open competition....
This is a $306,440.38 firm fixed price delivery order awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc. for chemistry analyzers and lab reagents. The contract is under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule and has a period of performance through June 30, 2026. Ortho-Clinical Diagnostics is a for-profit medical equipment manufacturer that has previously provided diagnostic solutions, reagents, and services to federal agencies including the...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the lease of one (1) chemical analyzer for the 66th Medical Squadron. The contract, awarded on January 1, 2022, has a ceiling value of $153,157.90 and an ultimate completion date of December 31, 2025. The contract does not have a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a...
This is a $1,037.23 firm fixed-price delivery order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the supply of 150 ml monoclonal anti-D reagent. The contract has an ultimate completion date of November 25, 2024 and does not utilize any set-aside designations. Ortho-Clinical Diagnostics is a provider of medical diagnostic solutions, including COVID-19 tests and immunodiagnostic/clinical chemistry analyzers, and...
The Defense Health Agency (DHA) awarded a $674,680.51 firm-fixed-price purchase order contract to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for reagents and consumables for the Ortho Vision Analyzer. The contract has an ultimate completion date of September 30, 2027. The contract was not set aside for any specific business type. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and manufacturer of goods registered in SAM.gov. The...
This is a $85,482.80 firm fixed price purchase order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for a procurement of MTS A/B/D/MONO GRP 5X20 items. The contract has an ultimate completion date of September 5, 2026. The contract was awarded on October 1, 2021 and was not set aside for any special program. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that has provided medical...
This is a definitive contract awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in Raritan, New Jersey. The contract, valued at $880,348.70, is for the provision of clinical chemistry reagents under CLIN 0001. The contract has a firm fixed price structure and an ultimate completion date of January 20, 2030. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and a manufacturer of goods, and...